129 related articles for article (PubMed ID: 1388645)
1. Bromocriptine reverses the elevation in intracranial self-stimulation thresholds observed in a rat model of cocaine withdrawal.
Markou A; Koob GF
Neuropsychopharmacology; 1992 Nov; 7(3):213-24. PubMed ID: 1388645
[TBL] [Abstract][Full Text] [Related]
2. Postcocaine anhedonia. An animal model of cocaine withdrawal.
Markou A; Koob GF
Neuropsychopharmacology; 1991 Jan; 4(1):17-26. PubMed ID: 2003866
[TBL] [Abstract][Full Text] [Related]
3. Desmethylimipramine attenuates cocaine withdrawal in rats.
Markou A; Hauger RL; Koob GF
Psychopharmacology (Berl); 1992; 109(3):305-14. PubMed ID: 1365631
[TBL] [Abstract][Full Text] [Related]
4. Estradiol lowers intracranial self-stimulation thresholds and enhances cocaine facilitation of intracranial self-stimulation in rats.
Galankin T; Shekunova E; Zvartau E
Horm Behav; 2010 Nov; 58(5):827-34. PubMed ID: 20736014
[TBL] [Abstract][Full Text] [Related]
5. Intracranial self-stimulation reward thresholds during morphine withdrawal in rats bred for high (HiS) and low (LoS) saccharin intake.
Holtz NA; Radke AK; Zlebnik NE; Harris AC; Carroll ME
Brain Res; 2015 Mar; 1602():119-26. PubMed ID: 25582876
[TBL] [Abstract][Full Text] [Related]
6. The GABAB receptor-positive modulator GS39783 and the GABAB receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: intracranial self-stimulation studies in the rat.
Slattery DA; Markou A; Froestl W; Cryan JF
Neuropsychopharmacology; 2005 Nov; 30(11):2065-72. PubMed ID: 15841108
[TBL] [Abstract][Full Text] [Related]
7. Withdrawal from chronic cocaine administration induces deficits in brain reward function in C57BL/6J mice.
Stoker AK; Markou A
Behav Brain Res; 2011 Sep; 223(1):176-81. PubMed ID: 21557971
[TBL] [Abstract][Full Text] [Related]
8. Postcocaine depression and sensitization of brain-stimulation reward: analysis of reinforcement and performance effects.
Kokkinidis L; McCarter BD
Pharmacol Biochem Behav; 1990 Jul; 36(3):463-71. PubMed ID: 2377648
[TBL] [Abstract][Full Text] [Related]
9. Blockade of nicotinic acetylcholine or dopamine D1-like receptors in the central nucleus of the amygdala or the bed nucleus of the stria terminalis does not precipitate nicotine withdrawal in nicotine-dependent rats.
Jonkman S; Markou A
Neurosci Lett; 2006 May; 400(1-2):140-5. PubMed ID: 16563623
[TBL] [Abstract][Full Text] [Related]
10. Reduction of zif268 messenger RNA expression during prolonged withdrawal following "binge" cocaine self-administration in rats.
Mutschler NH; Miczek KA; Hammer RP
Neuroscience; 2000; 100(3):531-8. PubMed ID: 11098116
[TBL] [Abstract][Full Text] [Related]
11. Effects of the anticonvulsant lacosamide compared to valproate and lamotrigine on cocaine-enhanced reward in rats.
Béguin C; Potter DN; Carlezon WA; Stöhr T; Cohen BM
Brain Res; 2012 Oct; 1479():44-51. PubMed ID: 22940183
[TBL] [Abstract][Full Text] [Related]
12. The triple reuptake inhibitor DOV 216,303 induces long-lasting enhancement of brain reward activity as measured by intracranial self-stimulation in rats.
Prins J; Kenny PJ; Doomernik I; Schreiber R; Olivier B; Mechiel Korte S
Eur J Pharmacol; 2012 Oct; 693(1-3):51-6. PubMed ID: 23010469
[TBL] [Abstract][Full Text] [Related]
13. Effects of oxytocin on nicotine withdrawal in rats.
Manbeck KE; Shelley D; Schmidt CE; Harris AC
Pharmacol Biochem Behav; 2014 Jan; 116():84-9. PubMed ID: 24239789
[TBL] [Abstract][Full Text] [Related]
14. Withdrawal following cocaine self-administration decreases regional cerebral metabolic rate in critical brain reward regions.
Hammer RP; Pires WS; Markou A; Koob GF
Synapse; 1993 May; 14(1):73-80. PubMed ID: 8511720
[TBL] [Abstract][Full Text] [Related]
15. Blockade of kappa opioid receptors attenuates the development of depressive-like behaviors induced by cocaine withdrawal in rats.
Chartoff E; Sawyer A; Rachlin A; Potter D; Pliakas A; Carlezon WA
Neuropharmacology; 2012 Jan; 62(1):167-76. PubMed ID: 21736885
[TBL] [Abstract][Full Text] [Related]
16. A dual approach to self-stimulation and locomotor trace affected by chronic methamphetamine treatment for an animal model of schizophrenia.
Takigawa M; Maeda H; Ueyama K; Tominaga H; Matsumoto K
Can J Physiol Pharmacol; 1993; 71(5-6):321-5. PubMed ID: 8402397
[TBL] [Abstract][Full Text] [Related]
17. Tolerance to cocaine in brain stimulation reward following continuous cocaine infusions.
Pudiak CM; KuoLee R; Bozarth MA
Pharmacol Biochem Behav; 2014 Jul; 122():246-52. PubMed ID: 24768900
[TBL] [Abstract][Full Text] [Related]
18. Severe deficit in brain reward function associated with fentanyl withdrawal in rats.
Bruijnzeel AW; Lewis B; Bajpai LK; Morey TE; Dennis DM; Gold M
Biol Psychiatry; 2006 Mar; 59(5):477-80. PubMed ID: 16169528
[TBL] [Abstract][Full Text] [Related]
19. Cocaine abstinence following chronic treatment alters cerebral metabolism in dopaminergic reward regions. Bromocriptine enhances recovery.
Clow DW; Hammer RP
Neuropsychopharmacology; 1991 Jan; 4(1):71-5. PubMed ID: 2003868
[TBL] [Abstract][Full Text] [Related]
20. The effect of chronic cocaine on self-stimulation train-duration thresholds.
Frank RA; Martz S; Pommering T
Pharmacol Biochem Behav; 1988 Apr; 29(4):755-8. PubMed ID: 3413201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
